GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $51 | -99.8% | 18,184 | +65.1% | 0.00% | – |
| Q2 2022 | $27,000 | -97.0% | 11,016 | -94.9% | 0.00% | -100.0% |
| Q1 2022 | $887,000 | +639.2% | 215,328 | +1544.6% | 0.01% | +1000.0% |
| Q2 2021 | $120,000 | -20.0% | 13,093 | -17.6% | 0.00% | -50.0% |
| Q1 2021 | $150,000 | +28.2% | 15,893 | -46.3% | 0.00% | +100.0% |
| Q4 2020 | $117,000 | – | 29,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,005,894 | $43,264,000 | 17.91% |
| FRAZIER MANAGEMENT LLC | 4,667,242 | $50,406,000 | 4.03% |
| EcoR1 Capital, LLC | 5,560,748 | $60,056,000 | 2.09% |
| Palo Alto Investors LP | 2,356,282 | $25,448,000 | 1.54% |
| Avidity Partners Management LP | 4,457,831 | $48,145,000 | 1.07% |
| BVF INC/IL | 1,528,072 | $16,503,000 | 0.64% |
| Redmile Group, LLC | 2,821,085 | $30,468,000 | 0.53% |
| ACT CAPITAL MANAGEMENT, LLC | 74,000 | $799,000 | 0.41% |
| DG Capital Management, LLC | 83,162 | $898,000 | 0.18% |
| HighVista Strategies LLC | 14,453 | $156,000 | 0.10% |